Clinical Trial: MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian Patients
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Metabolic- Associated Fatty Liver Disease (MAFLD)
Study Type: OBSERVATIONAL
Official Title: The Accuracy of MAFLD Fibrosis Score in Detecting Fibrotic NASH in MAFLD Egyptian Patients
Brief Summary:
Metabolic-associated fatty liver disease (MAFLD), is a metabolic stress-induced liver injury characterized by diffuse hepatocyte macrovesicular fatty infiltration.The incidence of MAFLD is increasing yearly, and its incidence rate is as high as 20% to 30% on a global scale, which seriously affects people's health.Non-alcoholic steatohepatitis (NASH), a chronic hepatitis that can progress to advanced fibrosis, decompensated cirrhosis, and hepatocellular carcinoma, affects one-fifth of NAFLD patients.Depending…
Read more